title: Liver disease secondary to intestinal failure.
abstract: IFALD is a common and potentially life-threatening condition for patients with SBS requiring long-term PN. There exists the potential for decreasing its incidence by optimizing the composition and the rate of infusion of parenteral solutions, by advocating a multidisciplinary approach, and by early referral for intestinal-liver transplantation to ensure long-term survival of patients with SBS.
authors.affiliation: Queen Elizabeth II Health Sciences Centre, Dalhousie University, 1276 South Park Street, Office 6-302 Victoria Building, Halifax, NS, Canada B3H 2Y9.
authors.forename: Bassam
authors.initials: B
authors.lastname: Abu-Wasel
authors.affiliation: Queen Elizabeth II Health Sciences Centre, Dalhousie University, 1276 South Park Street, Office 6-302 Victoria Building, Halifax, NS, Canada B3H 2Y9.
authors.forename: Michele
authors.identifier: 0000-0001-7877-2703
authors.initials: M
authors.lastname: Molinari
mesh_terms: D006801:Humans; D007410:Intestinal Diseases / Q000150:complications / Q000503:physiopathology; D008107:Liver Diseases / Q000209:etiology / Q000503:physiopathology